Study guide

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness

Key Takeaways Explain This Topic AI

Burn size is estimated using the Wallace rule of nines or the Lund and Browder chart (more accurate in children), counting only partial- and full-thickness burns; formal fluid resuscitation is usually needed above about 15% total body surface area in adults and 10% in children.

The Parkland formula estimates crystalloid for the first 24 hours as 4 mL/kg per % burn, half in the first 8 hours from the time of injury, but infusion is titrated to a urine output of about 0.5 mL/kg/h in adults to avoid over-resuscitation.

Early intubation is indicated for burns with airway oedema or stridor, deep facial or circumferential neck burns, or reduced consciousness, because swelling progresses over the first 24-48 hours.

Suxamethonium is safe in the first 24-48 hours after a burn but should be avoided from about 48 hours until wound healing because of hyperkalaemia, while patients become resistant to non-depolarising blockers.

Accidental hypothermia below 30 °C increases the risk of ventricular fibrillation; in cardiac arrest, defibrillation attempts and adrenaline are limited until rewarming, and extracorporeal life support offers the best chance of survival.

Last updated: October 2026

  • 25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness
  • Burns
  • Assessment

Depth: superficial (epidermal, red, painful; not counted in burn size), superficial partial-thickness (blisters, painful, blanching), deep partial-thickness (mottled, reduced sensation), full-thickness (white or leathery, painless).

Size (total body surface area, TBSA): the Wallace rule of nines in adults (head 9%, each arm 9%, front of trunk 18%, back 18%, each leg 18%, perineum 1%), the Lund and Browder chart (adjusts for age, as children have relatively larger heads), and the patient's palm with fingers (about 1%) for small or scattered burns.

Referral criteria include large burns, burns to the face, hands, feet, perineum or joints, circumferential and electrical or chemical burns, inhalation injury and burns in young children or the elderly.

Pathophysiology

Burns cause local and systemic release of inflammatory mediators, increased capillary permeability and loss of plasma into the tissues, maximal in the first 8-12 hours and lasting about 24-48 hours. This causes burn shock (hypovolaemic and distributive), followed by a hypermetabolic phase with raised cardiac output, oxygen consumption and catabolism that can last months.

Fluid Resuscitation

Usually needed above about 15% TBSA in adults and 10% in children .

Parkland formula: Volume (mL) = 4 × weight (kg) × % TBSA \text{Volume (mL)} = 4 \times \text{weight (kg)} \times \%\text{TBSA} Volume (mL) = 4 × weight (kg) × % TBSA of crystalloid (Hartmann's) over 24 hours, with half in the first 8 hours from the time of the burn and half over the next 16 hours.

The formula is only a starting point. Titrate to urine output of about 0.5 mL/kg/h in adults (about 1 mL/kg/h in children under 30 kg, higher in electrical injuries with myoglobinuria).

"Fluid creep" (over-resuscitation) causes oedema, abdominal and limb compartment syndromes and pulmonary complications. Albumin may be added after about 12-24 hours to reduce crystalloid requirements.

Children need maintenance fluid with glucose in addition to resuscitation fluid.

Airway and Inhalation Injury

Upper airway thermal injury causes oedema that progresses over 24-48 hours, especially with fluid resuscitation. Signs: facial and neck burns, singed nasal hairs, soot in the mouth, hoarse voice, stridor, carbonaceous sputum.

Early intubation with an uncut tube (to allow for facial swelling) is indicated for stridor or airway compromise, deep facial or circumferential neck burns, reduced consciousness, or the need for safe transfer. Delayed intubation can become impossible.

Lower airway injury results from chemical irritants in smoke, causing bronchospasm, impaired ciliary function, mucosal sloughing, casts and pneumonia. Diagnosis is by bronchoscopy. Treatment includes lung-protective ventilation, bronchodilators, and nebulised heparin and N-acetylcysteine in some centres.

Smoke Toxins

Toxin Clinical clues Treatment

Carbon monoxide Headache, confusion, coma; pulse oximetry falsely normal; raised carboxyhaemoglobin on co-oximetry 100% oxygen; hyperbaric oxygen in selected cases

Hydrogen cyanide (burning plastics, wool) Severe lactic acidosis (above about 8-10 mmol/L), cardiovascular collapse, high venous oxygen saturation Hydroxocobalamin 5 g IV

Circumferential Burns

Full-thickness circumferential burns of the chest restrict ventilation and those of limbs cause ischaemia; escharotomy releases them.

Anaesthesia for Burn Patients

Suxamethonium: safe in the first 24-48 hours ; avoid from about 48 hours until the burn has healed (and for some time after) because of upregulated extrajunctional receptors and hyperkalaemia .

Resistance to non-depolarising blockers develops from about 1 week, requiring larger doses (up to two to five times).

Increased opioid requirements (tolerance, hypermetabolism).

Blood loss during excision and grafting is large (about 2-4% of blood volume per 1% TBSA excised in some estimates); use tourniquets, topical adrenaline and tranexamic acid.

Temperature control: warm the theatre (about 28-32 °C), warm fluids and use active warming, as burned patients lose heat rapidly.

Monitoring may be difficult (ECG needle electrodes, alternative oximetry sites).

Electrical Injury

Low-voltage (below 1,000 V) alternating current causes arrhythmias, especially ventricular fibrillation; high-voltage injury and lightning cause deep tissue damage disproportionate to skin burns, rhabdomyolysis , compartment syndrome and asystole. Lightning causes massive direct current and may cause respiratory arrest that outlasts cardiac arrest. Monitor the ECG, check creatine kinase, and maintain high urine output if myoglobinuria is present.

Drowning

Drowning is respiratory impairment from submersion or immersion in liquid. The key injury is hypoxia .

Resuscitation: start with 5 rescue breaths because the arrest is hypoxic, then standard CPR. Do not attempt to drain water from the lungs.

Salt and fresh water aspiration both wash out surfactant and cause pulmonary oedema and ARDS; the distinction is clinically unimportant.

Consider cervical spine injury only if the history suggests diving or trauma.

Hypothermia may protect the brain in cold-water immersion; prolonged resuscitation may be appropriate.

Accidental Hypothermia

  • Stage (Swiss system) Core temperature Features
  • Mild 32-35 °C Shivering, conscious
  • Moderate 28-32 °C Impaired consciousness, shivering stops
  • Severe Below 28 °C Unconscious

Cardiac arrest risk Below about 24 °C High risk of arrest (ventricular fibrillation risk rises below about 30 °C)

ECG: bradycardia, J (Osborn) waves, prolonged intervals, atrial fibrillation.

Management:

Handle gently (movement can trigger ventricular fibrillation), remove wet clothes, insulate, and use active external rewarming (forced air) for mild and moderate hypothermia.

In cardiac arrest , ERC guidance limits defibrillation to three attempts and withholds adrenaline when the core temperature is below 30 °C , and doubles the interval between adrenaline doses (6-10 minutes) between 30 and 35 °C.

Extracorporeal life support (venoarterial ECMO or cardiopulmonary bypass) is the preferred rewarming method for hypothermic cardiac arrest or unstable patients; survival with good neurological outcome is possible after prolonged CPR.

A serum potassium above about 12 mmol/L suggests asphyxia or a non-survivable injury; scores such as HOPE help decide on ECLS.

"Nobody is dead until warm and dead" applies, within these limits.

Heat Illness

Heat exhaustion: core temperature usually below 40 °C, normal mental state; rest, cooling and fluids.

Heat stroke: core temperature above about 40 °C with central nervous system dysfunction (confusion, seizures, coma). Exertional heat stroke affects athletes and soldiers; classic heat stroke affects the elderly in heat waves. Complications include rhabdomyolysis, acute kidney injury, liver failure, DIC and ARDS.

Treatment: rapid cooling (cold-water immersion is the most effective for exertional heat stroke; evaporative cooling, ice packs), aiming for a core temperature of about 38.5-39 °C within 30 minutes. Antipyretics are ineffective; dantrolene is not recommended.

Differential diagnosis: malignant hyperthermia, neuroleptic malignant syndrome, serotonin syndrome, thyroid storm and sympathomimetic toxicity.

Decompression Illness

Includes decompression sickness (nitrogen bubbles forming in tissues and blood during or after ascent from depth) and arterial gas embolism (from pulmonary barotrauma during rapid ascent).

Decompression sickness: joint pain ("the bends"), skin mottling, neurological symptoms (spinal cord), and pulmonary "chokes".

Arterial gas embolism: sudden neurological deficit or loss of consciousness within minutes of surfacing.

Treatment: 100% oxygen, fluids, lie flat, and urgent hyperbaric oxygen recompression . Air transfer should be at low altitude or with a cabin pressurised to sea level.

Flying is avoided for at least 12-24 hours after diving (longer after multiple dives or dives needing decompression stops) to prevent decompression sickness.